Evofem extends merger outside date with Aditxt to Jan 31, 2025

Evofem Biosciences, Inc.

Fourth Amendment to Amended and Restated Merger Agreement dated Nov 19, 2024.
Changes required consummation date from Nov 29, 2024 to Jan 31, 2025.
Amendment modifies only Section 8.1(b)(ii); all other terms unchanged.

item 1.01 item 9.01

Evofem Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-047613

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.